Kim Yun Jeong, Ko Hyun Hee, Han Eun Sook, Lee Chung Soo
Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul 156-756, South Korea.
Brain Res Bull. 2007 Mar 30;71(6):633-40. doi: 10.1016/j.brainresbull.2006.12.006. Epub 2007 Jan 8.
Defects in mitochondrial function have been shown to participate in the induction of neuronal cell injury. The aim of the present study was to assess the effect of antiepileptic lamotrigine against the cytotoxicity of mitochondrial respiratory complex I inhibitors rotenone and 1-methyl-4-phenylpyridinium (MPP+) in relation to the mitochondria-mediated cell death process and oxidative stress. Both rotenone and MPP+ induced the nuclear damage, the changes in the mitochondrial membrane permeability, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species and the depletion of GSH in differentiated PC12 cells. Lamotrigine significantly attenuated the rotenone- or MPP+-induced mitochondrial damage leading to caspase-3 activation, increased oxidative stress and cell death. The preventive effect of lamotrigine against the toxicity of rotenone was greater than its effect on that of MPP+. The results show that lamotrigine seems to reduce the cytotoxicity of rotenone and MPP+ by suppressing the mitochondrial permeability transition formation, leading to cytochrome c release and subsequent activation of caspase-3. The preventive effect may be ascribed to its inhibitory action on the formation of reactive oxygen species and depletion of GSH. Lamotrigine seems to exert a protective effect against the neuronal cell injury due to the mitochondrial respiratory complex I inhibition.
线粒体功能缺陷已被证明参与神经元细胞损伤的诱导过程。本研究的目的是评估抗癫痫药物拉莫三嗪针对线粒体呼吸复合物I抑制剂鱼藤酮和1-甲基-4-苯基吡啶鎓(MPP+)的细胞毒性作用,及其与线粒体介导的细胞死亡过程和氧化应激的关系。鱼藤酮和MPP+均可诱导分化的PC12细胞发生核损伤、线粒体膜通透性改变,导致细胞色素c释放和半胱天冬酶-3激活、活性氧生成以及谷胱甘肽耗竭。拉莫三嗪可显著减轻鱼藤酮或MPP+诱导的线粒体损伤,从而导致半胱天冬酶-3激活、氧化应激增加和细胞死亡。拉莫三嗪对鱼藤酮毒性的预防作用大于其对MPP+毒性的作用。结果表明,拉莫三嗪似乎通过抑制线粒体通透性转换的形成来降低鱼藤酮和MPP+的细胞毒性,进而导致细胞色素c释放及随后半胱天冬酶-3的激活。这种预防作用可能归因于其对活性氧生成和谷胱甘肽耗竭的抑制作用。拉莫三嗪似乎对因线粒体呼吸复合物I抑制所致的神经元细胞损伤具有保护作用。